Skip to main content
. 2022 Oct 19;13:965694. doi: 10.3389/fphar.2022.965694

TABLE 3.

The crucial active components in BYLY.

Molecular id Molecular name Degree Counts of core regulatory targets Oral bioavailability (OB)% Drug-like (DL)
MOL000098 Quercetin 141 96 46.43 0.28
MOL000422 Kaempferol 59 39 41.88 0.24
MOL000006 Luteolin 55 44 36.16 0.25
MOL000173 Wogonin 45 32 30.68 0.23
MOL000378 7-O-methylisomucronulatol 44 25 74.69 0.30